CXCL5 and pancreatic adenocarcinoma: The expressions of CXCL5 (HR = 1.6; p = 0.024), CXCL9 (HR = 1.7; p = 0.012), CXCL10 (HR = 1.8; p = 0.0044), CXCL11 (HR = 1.6; p = 0.034), and CXCL17 (HR = 1.8; p = 0.0056) are connected with unfavorable OS of patients with PAAD (Figure 8).